Company / SG&A per Share
Bio-Techne SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$3.72
FY2025
5-year range
$2.07 / $6.87
FY2021-FY2025
Trend
+25.7%
vs FY2024
Sector context
#96 of 156
Health Care
What the data says
At $3.72, Bio-Techne's sg&a per share ranks #61 of 156 in the Health Care sector. SG&A per Share has fluctuated over the past 10 years, ranging from $2.07 in FY2023 to $7.03 in FY2019.
Based on SEC 10-K filings.
3.72 in FY2025 with a 5-year CAGR of -11.5%.
Increased from $2.07 to $3.72 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -17.8%
- 5-Year CAGR
- -11.5%
- 10-Year CAGR
- -
Sector benchmark
#61 of 156 in Health CareTop 38% of 156This company $3.72 Sector average $11421.56
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 25.7% year-over-year.
- Ranks #96 out of 156 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2019.
- Lowest sg&a per share in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.72 | +25.7% |
| FY2024 | $2.96 | +42.6% |
| FY2023 | $2.07 | -69.0% |
| FY2022 | $6.69 | -2.7% |
| FY2021 | $6.87 | +0.1% |
| FY2020 | $6.87 | -2.3% |
| FY2019 | $7.03 | +11.2% |
| FY2018 | $6.32 | +17.5% |
| FY2017 | $5.38 | +41.9% |
| FY2016 | $3.79 | +17.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026